DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Aurobindo Pharma Limited
03 1Cipla Ltd.
04 1Fagron Inc
05 1Glaxo Operations UK Ltd
06 1Hetero Labs Limited
07 1Hubei Gedian Humanwell Pharmaceutical Co.,Ltd
08 1Hubei Gedian humanwell Pharmaceutical Co., Ltd
09 1LETCO MEDICAL, LLC
10 1MSN Laboratories Private Limited
11 1Medisca Inc.
12 1Pharma Source Direct, Inc.
13 1Professional Compounding Centers of America
14 2STERLING SPA
15 2Sterling Chemical Malta Ltd
16 1Sterling S.p.A.
17 1ThermoFisher Scientific Cork
18 1Willow Birch Pharma, INC.
01 8DUTASTERIDE
02 11Dutasteride
03 1dutasteride
01 2China
02 5India
03 3Italy
04 2Malta
05 1Netherlands
06 5U.S.A
07 2United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-076
Start Marketing Date : 2012-08-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7612
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1551
Start Marketing Date : 2018-02-09
End Marketing Date : 2026-02-28
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51508-006
Start Marketing Date : 2015-02-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51508-207
Start Marketing Date : 2024-11-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3086
Start Marketing Date : 2022-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0006
Start Marketing Date : 2010-03-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-5120
Start Marketing Date : 2020-11-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 59057-004
Start Marketing Date : 2015-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-152
Start Marketing Date : 2023-06-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Dutasteride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dutasteride, including repackagers and relabelers. The FDA regulates Dutasteride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dutasteride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dutasteride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dutasteride supplier is an individual or a company that provides Dutasteride active pharmaceutical ingredient (API) or Dutasteride finished formulations upon request. The Dutasteride suppliers may include Dutasteride API manufacturers, exporters, distributors and traders.
click here to find a list of Dutasteride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dutasteride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dutasteride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dutasteride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dutasteride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dutasteride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dutasteride suppliers with NDC on PharmaCompass.
We have 16 companies offering Dutasteride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
